Can we legally purchase and consume marijuana in France today? Yes and no. Yes, due to the fact that the state has actually relaxed its policies on CBD, consisting of through the Minister of Health. And no, at the same time, due to the fact that only products containing cannabidiol (CBD), an active compound that does not have the psychoactive impacts attributed to THC, are thought about legal. Let us analyze what is legal and what is not with regard to marijuana and CBD.

CBD is legal in France, however THC is not

Marijuana ought to not be confused with cannabidiol. Specifically because the 2nd is legal in specific forms in France … While the other is not! Since cannabidiol (known by the acronym CBD) is simply among the many active substances from the hemp plant, which does not have the psychoactive impacts of its cousin THC – the one that makes you “stone”.

Simply put, what is generally called “marijuana”, which contains high concentrations of THC (tetrahydrocannabinol) is still thought about a narcotic product. And for that reason prohibited in France as in lots of countries on earth. On the other hand, marijuana which provides pride of place to the cannabinoid called cannabidiol, it is legal as long as its THC levels do not surpass 0.2%.

Nevertheless, the legislation stays vague in France on this subject. Presently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in a smokeless cigarette. However it is likewise discovered in other forms (consisting of oil or paste), without its purchase and usage being reprehensible … To attempt to make it simple, let’s state that CBD is not restricted by French law, unlike THC

CBD vs THC.

Although CBD and THC are equivalent, they are very different. These are the very best known of the 500 cannabinoids discovered in hemp. And each has its specific impacts. THC is especially known for its psychoactive residential or commercial properties: it causes a change in the state of consciousness by acting straight on the brain. By consuming marijuana abundant in THC, we “hover”: well-being, ecstasy, relaxation … But likewise red eyes, dilated pupils and, often, anxiety and even paranoia.

CBD has nothing to do with it. It is not euphoric. It does not cause anxiety or anxiety attacks. On the contrary: cannabidiol remains in the process of making its way by virtue of its helpful healing impacts. CBD helps ease pain and swelling, minimize anxiety, reduce the suffering of victims of anxiety attacks and depression, and even deal with specific illness (such as epilepsy or Alzheimer’s). In addition, it has a very low toxicity and presents (practically) no addicting danger, even if the lack of clinical research studies reduces these characteristics to simple hypotheses.

Legalization of CBD in France: should we go even more?

Definitely, the legal development regarding CBD is positive, however everything stays to be done. The health ministry wants to beware, and the federal government’s position on the matter resembles a balancing act. At the same time, the National Medicines Agency has actually plainly spoken out. We for that reason look after the goat and the cabbage so as not to get too included, while the vaporized cannabidiol has actually been readily available in France for a couple of years currently, benefiting from the legal vagueness that persists.

Beyond the 0.2% THC limit licensed in marketed products, it ought to be remembered that only the liquid type of CBD (planned for smokeless cigarettes) is actually legal. The purchase and usage of resin or smoking herb is for that reason not managed, especially because the THC level is often higher (around 15%). In addition, only the use of seeds and fibers is licensed in France. However what about one world CBD oil, which permits you to enjoy the advantages of the compound without exposing your lungs to potentially damaging smoke? What about CBD paste? On these topics, there is radio silence.

In addition, composite CBD is thought about a “dietary supplement”, which restricts presenting it as a medicine. And make it an informed advertisement for users and patients. Too bad, due to the fact that, in the meantime, lots of possible recipients are not benefiting from it. It is for that reason needed to go even more and clarify things: more than a question of customer well-being, it refers public health.

Scroll to top